Madrigal Pharmaceuticals Inc
F:YDO1
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
M
|
Madrigal Pharmaceuticals Inc
F:YDO1
|
US |
|
Teva Pharmaceutical Industries Ltd
NYSE:TEVA
|
IL |
|
K
|
Kinross Gold Corp
XBER:KIN2
|
CA |
|
Albertsons Companies Inc
NYSE:ACI
|
US |
|
Panasonic Holdings Corp
TSE:6752
|
JP |
|
Open House Group Co Ltd
TSE:3288
|
JP |
|
S
|
Seatrium Limited
SWB:S8N
|
SG |
|
M
|
Madrigal Pharmaceuticals Inc
LSE:0JXI
|
US |
|
D
|
Deere & Co
DUS:DCO
|
US |
|
A
|
Allegion PLC
F:60A
|
IE |
|
ANTA Sports Products Ltd
HKEX:2020
|
CN |
|
P
|
Procter & Gamble Co
DUS:PRG
|
US |
|
Fraport AG Frankfurt Airport Services Worldwide
F:FRA
|
DE |
|
Independence Realty Trust Inc
F:5O2
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
C
|
Clean Harbors Inc
SWB:CH6
|
US |
|
B
|
Basf Se
XBER:BAS
|
DE |
|
Industrials REIT Ltd
LSE:MLI
|
UK |
|
S
|
Shin-Etsu Chemical Co Ltd
XBER:SEH
|
JP |
|
F
|
Ford Motor Co
XHAM:FMC1
|
US |
|
Adient PLC
F:18I
|
IE |
|
S
|
Sumitomo Corp
F:SUMB
|
JP |
Bankruptcy Probability
Madrigal Pharmaceuticals Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Madrigal Pharmaceuticals Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Madrigal Pharmaceuticals Inc
NASDAQ:MDGL
|
12.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| JP |
|
Takara Bio Inc
TSE:4974
|
120.4T JPY |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
461.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
202B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
134.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
69.2B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
51.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Madrigal Pharmaceuticals Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Madrigal Pharmaceuticals Inc has total debt of 340.3m USD. This includes both short-term (0 USD) and long-term (340.3m USD) debt.
You can find a full breakdown on its Balance Sheet.
